Brendan Nicholas is the Senior Director of Finance at Pheon Therapeutics, an antibody-drug conjugate company. He has deep expertise in biotech finance, with previous leadership roles at Vedere Bio II, 2seventy bio, and bluebird bio. He earned his degree in Finance from Bryant University.
Colleagues have described him as being "IT savvy" and someone who is "always willing to go above and beyond" to support his peers and business partners.
He has unique experience managing financial operations through complex corporate transitions, including a company spinout and a wind-down.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.